128 related articles for article (PubMed ID: 28054535)
1. Combined prednisolone and pirfenidone in bleomycin-induced lung disease.
Vaidya PJ; Sandeepa HS; Singh T; Susheel Kumar SK; Bhargava R; Ramakrishnan G; Chhajed PN
J Cancer Res Ther; 2016; 12(3):1198-1202. PubMed ID: 28054535
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.
Sakamoto K; Ito S; Hashimoto N; Hasegawa Y
BMC Cancer; 2017 Aug; 17(1):526. PubMed ID: 28784103
[TBL] [Abstract][Full Text] [Related]
3. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
4. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
[TBL] [Abstract][Full Text] [Related]
5. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
6. Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.
Chilakapati SR; Serasanambati M; Manikonda PK; Chilakapati DR; Watson RR
Can J Physiol Pharmacol; 2014 Aug; 92(8):631-9. PubMed ID: 24933624
[TBL] [Abstract][Full Text] [Related]
7. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
8. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
Oltmanns U; Kahn N; Palmowski K; Träger A; Wenz H; Heussel CP; Schnabel PA; Puderbach M; Wiebel M; Ehlers-Tenenbaum S; Warth A; Herth FJ; Kreuter M
Respiration; 2014; 88(3):199-207. PubMed ID: 25115833
[TBL] [Abstract][Full Text] [Related]
10. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
Iwasawa T; Ogura T; Sakai F; Kanauchi T; Komagata T; Baba T; Gotoh T; Morita S; Yazawa T; Inoue T
Eur J Radiol; 2014 Jan; 83(1):32-8. PubMed ID: 22465123
[TBL] [Abstract][Full Text] [Related]
11. [Antineoplastic drug-induced pneumonitis-fibrosis].
Oizumi K; Nakai Y; Konno K
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1217-24. PubMed ID: 6206254
[TBL] [Abstract][Full Text] [Related]
12. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis.
Costabel U; Albera C; Bradford WZ; Hormel P; King TE; Noble PW; Sahn SA; Valeyre D; du Bois RM
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):198-205. PubMed ID: 25363219
[TBL] [Abstract][Full Text] [Related]
13. Severe bleomycin lung toxicity: reversal with high dose corticosteroids.
Maher J; Daly PA
Thorax; 1993 Jan; 48(1):92-4. PubMed ID: 7679525
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
Bonella F; Wessendorf TE; Costabel U
Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
[TBL] [Abstract][Full Text] [Related]
17. [Bleomycin-induced pulmonary fibrosis following chemotherapy of ovarian granulosa cell tumor].
Theile A; Kemper P
Pneumologie; 1998 Jun; 52(6):325-32. PubMed ID: 9715647
[TBL] [Abstract][Full Text] [Related]
18. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.
Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B
J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
20. Revisiting bleomycin from pathophysiology to safe clinical use.
Froudarakis M; Hatzimichael E; Kyriazopoulou L; Lagos K; Pappas P; Tzakos AG; Karavasilis V; Daliani D; Papandreou C; Briasoulis E
Crit Rev Oncol Hematol; 2013 Jul; 87(1):90-100. PubMed ID: 23312772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
